SCHEMBL23301397

SCHEMBL23301397

[H+].c1ccc2c(c1)ccc1c(C3CCCC3)cccc12

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.50
SLC6A4 P31645 2/20 0.45
DRD2 P14416 1/20 0.45
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP2A6 P11509 1/20 0.43
TSHR P16473 1/20 0.43
CYP1B1 Q16678 2/20 0.42
MTNR1A P48039 1/20 0.41
KDM1A O60341 1/20 0.41
PAX8 Q06710 1/20 0.38
CYP1A2 P05177 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27546009 0.98 HPRT1 (0.52) HPRT1SLC6A4DRD2ALDH1A1HSD17B10
SCHEMBL7746921 0.96 HPRT1 (0.50) HPRT1SLC6A4DRD2ALDH1A1HSD17B10
SCHEMBL6567045 0.95 HPRT1 (0.52) HPRT1SLC6A4DRD2ALDH1A1HSD17B10
SCHEMBL497994 0.87 SLC6A4 (0.56) SLC6A4DRD2ALDH1A1HSD17B10TDP1
SCHEMBL28532229 0.86 HPRT1 (0.47) HPRT1SLC6A4DRD2ALDH1A1HSD17B10
SCHEMBL168782 0.85 SLC6A4 (0.54) SLC6A4DRD2ALDH1A1HSD17B10TDP1
SCHEMBL30032791 0.85 SLC6A4 (0.54) SLC6A4DRD2ALDH1A1HSD17B10TDP1
SCHEMBL4047901 0.85 SLC6A4 (0.54) SLC6A4DRD2ALDH1A1HSD17B10TDP1
SCHEMBL3968194 0.83 SLC6A4 (0.56) SLC6A4DRD2ALDH1A1HSD17B10TDP1
Methane SCHEMBL27919122 0.81 SLC6A4 (0.51) SLC6A4DRD2ALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021083336-A1 USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF GPR39 AGONIST 北京大学 2021-05-06 WO disclosed